Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18037080 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines
Condition: Infections, Rotavirus
Intervention: Biological: Rotavirus (vaccine)

Indicates status has not been verified in more than two years